As previously reported, Benchmark analyst Bill Sutherland upgraded Nobilis Health to Speculative Buy from Hold following the company's investor call yesterday during which it provided a business update and introduced new CEO Jim Springfield. The call did not provide a specific update on the company's still unfiled third quarter 10-Q, but "it sounds like a filing is not far away," Sutherland said. Additionally during the call, Nobilis announced that it signed an in-network contract at the Plano surgical hospital and said in-network deals are expected to be signed in the "near term" with two other large payers, Sutherland noted. He set a $2 price target on Nobilis Health shares.